N-Nitroso Metronidazole EP Impurity A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Metronidazole is an antibiotic. It's used to treat skin infections, rosacea and mouth infections, including infected gums and dental abscesses. It's also used to treat conditions such as bacterial vaginosis and pelvic inflammatory disease.N-Nitroso Metronidazole EP Impurity A is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Metronidazole EP Impurity A CAS No;NA chemically represented as 2-Methyl-5-nitro-1-nitroso-1H-imidazole . Synchemia is the leading manufacturing and exporter of N-Nitroso Metronidazole EP Impurity A . We supply N-Nitroso Metronidazole EP Impurity A with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143716 |
| CAS No | NA |
| Mol.F. | C25H22N8O6 |
| Mol.Wt. | 530.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143717 |
| CAS No | NA |
| Mol.F. | C27H29N9O5 |
| Mol.Wt. | 559.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143718 |
| CAS No | NA |
| Mol.F. | C27H31N9O3 |
| Mol.Wt. | 529.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143719 |
| CAS No | NA |
| Mol.F. | C26H27N9O5 |
| Mol.Wt. | 545.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143720 |
| CAS No | NA |
| Mol.F. | C26H29N9O3 |
| Mol.Wt. | 515.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143721 |
| CAS No | NA |
| Mol.F. | C30H33N9O4 |
| Mol.Wt. | 583.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143722 |
| CAS No | NA |
| Mol.F. | C29H31N9O4 |
| Mol.Wt. | 569.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143723 |
| CAS No | NA |
| Mol.F. | C16H19N3O7S |
| Mol.Wt. | 397.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143724 |
| CAS No | NA |
| Mol.F. | C15H19N3O5S |
| Mol.Wt. | 353.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143725 |
| CAS No | NA |
| Mol.F. | C32H37N5O5S |
| Mol.Wt. | 603.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143726 |
| CAS No | NA |
| Mol.F. | C48H55N7O9S2 |
| Mol.Wt. | 938.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143727 |
| CAS No | NA |
| Mol.F. | C16H19N3O6S |
| Mol.Wt. | 381.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143728 |
| CAS No | NA |
| Mol.F. | C16H18N215N2O2 |
| Mol.Wt. | 300.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143729 |
| CAS No | NA |
| Mol.F. | C32H37N5O5S |
| Mol.Wt. | 603.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143730 |
| CAS No | NA |
| Mol.F. | C16H19N215NO |
| Mol.Wt. | 270.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143731 |
| CAS No | NA |
| Mol.F. | C11H12D4N2O3 |
| Mol.Wt. | 228.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |